Abbott Laboratories buy Piper Jaffray Companies
Start price
19.09.24
/
50%
€103.70
Target price
19.09.25
€117.65
Performance (%)
12.09%
End price
20.09.25
€116.24
Summary
This prediction ended on 20.09.25 with a price of €116.24. The prediction had a final performance of 12.09%. Dividends of €1.08 are taken into consideration when calculating the performance. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -4.137% | -4.137% | -23.579% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $131.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Piper_Jaffray_Compan gewählte maximale Laufzeit wurde überschritten